+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Thalidomide"

Myelodysplastic Syndrome (MDS) Drugs Market Report 2025 - Product Thumbnail Image

Myelodysplastic Syndrome (MDS) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
From
From
Thalomide Pharmion - API Insight, 2022 - Product Thumbnail Image

Thalomide Pharmion - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Thalidomide is a drug used in the treatment of oncology, primarily multiple myeloma. It is an immunomodulatory agent, meaning it modulates the immune system to help fight cancer. It is also used to treat other conditions such as leprosy and erythema nodosum leprosum. Thalidomide is usually taken orally, but can also be administered intravenously. It is often used in combination with other drugs, such as corticosteroids, to increase its effectiveness. Thalidomide has been used in oncology for over 50 years, and is still used today. It is generally well-tolerated, with few side effects. However, it can cause serious birth defects if taken during pregnancy, so it is important to use contraception when taking the drug. The thalidomide market is highly competitive, with many companies offering the drug. Some of the major players in the market include Celgene, Teva Pharmaceuticals, and Mylan. Other companies include Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Natco Pharma. Show Less Read more